Darifenacin Hydrobromide
- Product NDC
- 42291-207
- 11-digit product format
- 422910207
- Labeler code
- 42291
- Product ID
- 42291-207_9c5c3dc2-4906-7e0b-e053-2995a90a5711
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Darifenacin Hydrobromide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AvKARE, Inc.
- Application
- ANDA091190
- Marketing category
- ANDA
- Marketing start
- 2017-01-09
- Marketing end
- 0000-00-00
- Substance
- DARIFENACIN HYDROBROMIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record